SORRENTO THERAPEUTICS, INC. Common Stock (par value $0.0001 per share) At Market Issuance Sales AgreementSorrento Therapeutics, Inc. • November 9th, 2017 • Services-commercial physical & biological research • New York
SORRENTO THERAPEUTICS, INC., IssuerIndenture • November 9th, 2017 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • New York
INDENTURE, dated as of , 20 , by and between Sorrento Therapeutics, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
